Mar 8, 2023 Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates
Mar 2, 2023 Avenue Therapeutics Enters into a Transformational License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201, a First-in-Class Clinical Asset for the Treatment of Spinal and Bulbar Muscular Atrophy
